C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2004
11/04/2004	WO2004094431A2 2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine a2a receptor antagonists
11/04/2004	WO2004094430A1 Tricyclic indole derivatives and their use in the treatment of alzheimer’s disease
11/04/2004	WO2004094429A1 Cannabinoid receptor ligands and uses thereof
11/04/2004	WO2004094428A1 4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7h-pyrrolo`2, 3d! pyrimidine hydrogen mesylate and its polymorphic forms
11/04/2004	WO2004094425A1 Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals
11/04/2004	WO2004094421A1 Cannabinoid receptor ligands and uses thereof
11/04/2004	WO2004094420A1 Condensed n-heterocyclic compounds and their use as crf receptor antagonists
11/04/2004	WO2004094419A1 Condensed n-heterocyclic compounds and their use as crf receptor antagonists
11/04/2004	WO2004094417A1 Cannabinoid receptor ligands and uses thereof
11/04/2004	WO2004093828A2 Reverse-turn mimetics and method relating thereto
11/04/2004	WO2004093812A2 Compounds that induce neuronal differentiation in embryonic stem cells
11/04/2004	WO2004093805A2 Selective spirocyclic glucocorticoid receptor modulators
11/04/2004	WO2004093798A2 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
11/04/2004	WO2004082577A3 8-SUBSTITUTED-6, 7, 8, 9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES
11/04/2004	WO2004050681A3 Kinase modulators
11/04/2004	US20040220406 Purifying triethylenediamine (TEDA) by distillation, wherein the fractionation is carried out in a dividing wall column
11/04/2004	US20040220405 Process for the preparation of highly pure triethylene diamine
11/04/2004	US20040220403 For therapy and prophylaxis of Tachykinin-mediated diseases
11/04/2004	US20040220222 Malonamide derivatives
11/04/2004	US20040220214 Pharmaceutical compositions and methods for effecting dopamine release
11/04/2004	US20040220194 2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
11/04/2004	US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004	US20040220189 anticancer agents; antidiabetic agents; restenosis; antiarthritic agents; skin disorders; antiinflammatory agents
11/04/2004	US20040220186 phosphodiesterase inhibitors
11/04/2004	US20040220178 Substituted heterocycle fused gamma-carbolines
11/04/2004	US20040220169 anticoagulants; factor x inhibitor; N-[1-(5-chloro-1H-benzimidazol-2-yl)ethyl]-3-methyl-4-(2,5-dihydropyrrol-1-ylcarbonyl)benzamide
11/04/2004	US20040220145 Methods for treating hearing loss
11/04/2004	DE10317817A1 Pyrrolopyrrole als fluoreszente Marker für Biomoleküle und sphärische Partikel Pyrrolopyrroles as fluorescent labels for biomolecules and spherical particles
11/04/2004	DE10315654A1 8-Nitro-Tryptanthrin und andere Tryptanthrin-Derivate zur Therapie von Erkrankungen, die durch hoch-proliferierende Zellen verursacht werden 8-nitro-tryptanthrine and other tryptanthrine derivatives for the treatment of diseases caused by high-proliferating cells
11/04/2004	CA2523364A1 Cannabinoid receptor ligands and uses thereof
11/04/2004	CA2523291A1 Tricyclic indole derivatives and their use in the treatment of alzheimer`s disease
11/04/2004	CA2523205A1 Cannabinoid receptor ligands and uses thereof
11/04/2004	CA2522946A1 Selective spirocyclic glucocorticoid receptor modulators
11/04/2004	CA2522810A1 4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7h-pyrrolo[2,3d]pyrimidine hydrogen mesylate and its polymorphic forms
11/04/2004	CA2521538A1 Cannabinoid receptor ligands and uses thereof
11/03/2004	EP1473068A1 Process for the preparation of pure triethylendiamine (TEDA)
11/03/2004	EP1472259A1 Tetrapyrrolic macrocycles as photodynamic agents
11/03/2004	EP1472258A1 Method for the synthesis of porphyrins and calix(4)pyrroles
11/03/2004	EP1472257A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
11/03/2004	EP1472256A1 Piperidine derivatives
11/03/2004	EP1472255A1 Aza-arylpiperazines
11/03/2004	EP1472252A1 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
11/03/2004	EP1472245A2 Heteroaryl compounds useful as inhibitors of gsk-3
11/03/2004	EP1471970A2 NOVEL MAMMALIAN MULTIPOTENT STEM CELLS AND COMPOSITIONS, METHODS OF PREPARATION AND METHODS OF ADMINISTRATION THEREOF
11/03/2004	EP1471918A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
11/03/2004	EP1471917A1 Use of pde5 inhibitors such as sildenafil in the treatment of polycystic ovary syndrome
11/03/2004	EP1471902A1 Methods for treating hearing loss
11/03/2004	EP1395584A4 Uronium and immonium salts for peptide coupling
11/03/2004	EP1261609B1 Triazolotriazinones and the use thereof
11/03/2004	CN1543467A Diazacycloalkanes as oxytocin agonists
11/03/2004	CN1543465A Novel heterocyclic compounds as selective bacterial DHFR inhibitors and their uses thereof
11/03/2004	CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004	CN1542010A Azolo triazines and pyrimidines
11/03/2004	CN1542009A Preparation method and use of dipyridanmole derivative
11/03/2004	CN1173991C Fik-1 as receiptor of growth factor of blood vessel inner-skin
11/03/2004	CN1173975C Imidazopyridine derivatives
11/02/2004	US6812343 Fluorescence, phosphorescence, electroconductivity
11/02/2004	US6812243 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation
11/02/2004	CA2103454C Macrocyclic immunomodulators
10/2004
10/28/2004	WO2004092176A1 Pyrrolo[1,2-b]pyridazine compounds and their uses
10/28/2004	WO2004092175A1 Heterobicyclic compounds used as fungicides
10/28/2004	WO2004092174A1 Pyrrolopyrroles used as fluorescent labels for biomolecules and spherical particles
10/28/2004	WO2004092173A2 A2a adenosine receptor antagonists
10/28/2004	WO2004092172A2 Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosin e receptor antagonists
10/28/2004	WO2004092171A2 Triazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines useful as a2a adenosin e receptor antagonists
10/28/2004	WO2004092170A2 Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagon ists
10/28/2004	WO2004092134A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004	WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	WO2004091613A2 Substituted phenyl acetamides and their use as protease inhibitors
10/28/2004	WO2004072030A3 Process for preparing pyrrolotriazine kinase inhibitors
10/28/2004	WO2004058726A3 CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST β-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE
10/28/2004	WO2004056827A3 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
10/28/2004	WO2004010512A3 Heteroatom-containing diamondoid transistors
10/28/2004	US20040214928 For therapy of proliferative disorders and neurological disorders
10/28/2004	US20040214876 Tetramerous derivative of indole-3-carbinol with anti-carcinogenic activity and method of synthesis of said derivative
10/28/2004	US20040214856 Cannabinoid receptor ligands and uses thereof
10/28/2004	US20040214855 Cannabinoid receptor ligands and uses thereof
10/28/2004	US20040214843 Such as spiro(cyclohexane-1-4'-(3',4'-dihydro)quinazolin)-2'(1'H)-one for treatment of T-cell-related diseases, autoimmune diseases, osteoarthritis, multiple sclerosis, osteoporosis, asthma and cancer
10/28/2004	US20040214840 producing 4-oxo-4,5-dihydro-3H-pyrrole[3,2-d]pyrimidine-7-carboxylic acid methyl ester by condensing 3-amino-1H-pyrrole-2,4-dicarboxylic acid dimethyl ester with formamidine acetate; precusor for 9-deaza-hypoxanthine, PNP inhibitor intermediate
10/28/2004	US20040214838 such as 6-benzyl-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-2,6-dihydropyrazolo[3,4-c]pyridin-7-one; for treatment of eating disorders and psychological disorders
10/28/2004	US20040214837 such as 3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-(4-methylpiperazin-1-yl)-2H-pyrazolo[4,3-d]pyrimidine; for treatment of eating disorders and psychological disorders
10/28/2004	US20040214828 the agronomic pesticide is combined with surfactants and solid or liquid diluents, and optionally combined with another active ingredient; nontoxic
10/28/2004	US20040214820 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them
10/28/2004	US20040214817 Diaminotriazoles useful as inhibitors of protein kinases
10/28/2004	US20040214814 Pyrazole compounds useful as protein kinase inhibitors
10/28/2004	US20040214812 4-Substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as beta-lactamase inhibitors
10/28/2004	US20040214810 octa(1,4,7,10-tetraoxaundecyl)Gadolinium-phthalocyanine for example; or manganese(II or III) complexes thereof; complex bound to a peptide or polysaccharide; enhancing tissue-specific contrast of magnetic resonance imaging
10/28/2004	CA2522480A1 Heterobicyclic compounds used as fungicides
10/28/2004	CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	CA2521364A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004	CA2520805A1 Pyrrolo[1,2-b]pyridazine compounds and their uses
10/27/2004	EP1471066A1 Triaza- and tetraaza-anthracenedione derivates, their preparation and their use as pharmaceuticals
10/27/2004	EP1471056A1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
10/27/2004	EP1471055A1 6-phenylpyridyl-2-amine derivatives
10/27/2004	EP1470139A2 NOVEL, WATER−SOLUBLE PORPHYRIN PLATINUM COMPOUNDS WITH HIGH TUMOR SELECTIVITY AND THEIR USE FOR THE TREATMENT OF BENIGN AND MALIGNANT TUMOR DISEASES
10/27/2004	EP1470127A1 N, n'-dimethylated n-confused porphyrins
10/27/2004	EP1470126A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
10/27/2004	EP1470123A1 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, related compositions and methods
10/27/2004	EP1469857A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis
10/27/2004	EP1469852A2 Nitric oxide donors for treatment of disease and injury

1 ... 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 ... 573